First patients enrolled in a phase Ib and a phase III studies

The Ib phase study will be conducted in patients with moderately to severely active ulcerative colitis, while a phase III study will enroll infants, children and adolescents with acute diarrhea

This is a multicenter, open-label, controlled, randomized clinical study of an investigational product in combination with standard treatment with oral rehydration solutions. It is planned to enroll more than 120 patients of several age groups, which will be randomized to two equal treatment arms.

Apart from enrollment-related activities, OCT is also responsible for study monitoring, project management, regulatory support, logistics, quality assurance and final report preparation.

OCT has a wide network of more than 1600 investigational sites. Our vast experience in different phases of trials and successful cooperation with principal investigators make it possible to achieve high enrollment rates.